The International Society for Stem Cell Research (ISSCR) is an independent, global, nonprofit organization that brings together the international stem cell community and helps guide how stem cell research advances toward improving human health. Through its work, the Society sets scientific, ethical, and clinical standards that are widely used around the world.
As Vice President, Malin Parmar will serve on the ISSCR Executive Committee for a four‑year leadership term, progressing through the roles of President‑elect, President, and Past President. Her election to the post reflects her international standing in the field and highlights the strong position of Lund University and the Lund Stem Cell Center in stem cell and regenerative medicine research.
We spoke with Professor Malin Parmar about what the election means to her and to the future direction of the field:
Q: What does this election mean to you personally?
“I am deeply honoured by the trust placed in me by the international stem cell community,” says Malin Parmar. “The ISSCR has played an important role throughout my career as a place for scientific exchange, collaboration, and thoughtful discussion about how our research moves toward patients.”
She adds that the timing is particularly meaningful. “Stem cell science is increasingly reaching the clinic. To help lead the Society during this phase is both exciting and a great responsibility.”
For Malin Parmar, the role is also about values. “As new therapies move closer to clinical use, it is essential that we uphold strong scientific standards, patient safety, and clear, evidence‑based communication. The ISSCR has a key role in setting that direction globally, including in addressing the growing importance of equitable access to stem cell therapies across different healthcare settings.”
Q: What does your election mean for Lund University and the Lund Stem Cell Center?
“This election is a recognition of the strong stem cell and regenerative medicine research environment at Lund University,” Malin Parmar says. “Our work, from basic stem cell biology to clinical translation, is built on long‑term strategic investment, collaboration across disciplines, and close interaction between researchers, clinicians, and technology platforms.”
She notes that the role also strengthens Lund’s international visibility. “My role as ISSCR vice president enhances Lund University’s presence on the global stage and creates new opportunities for collaboration, recruitment, and influence. It highlights that impactful, patient‑oriented stem cell research is being done here in Sweden.”
Q: What will be most important for the ISSCR in the coming years?
“The field is entering a decisive phase,” notes Malin Parmar. “We are seeing rapid advances across many areas, from stem cell‑derived therapies and organoids to cellular reprogramming and data‑driven approaches. These developments hold enormous promise, but they also require careful coordination across science, medicine, industry, regulatory authorities, and patient communities.”
Another key priority, she says, will be global engagement. “Stem cell research is truly international. Ensuring that the ISSCR remains an inclusive platform that supports scientists across regions, disciplines, and career stages, will be essential for progress that is innovative and responsible, and at the same time, equitable.”
